The bacon scare is built on a number nobody is explaining
Last week’s Grocer report on an £18.7 million fall in nitrite-cured bacon sales in twelve weeks was presented by the Coalition Against Nitrites as confirmation that the science has been settled and the public has passed its verdict. Neither claim is true. The sales figures are real but the scientific story behind them is not.
The risk data is being misrepresented
The number doing the damage is the WHO’s 2015 Group 1 carcinogen classification. A decade on, it sits in the public consciousness as proof that bacon causes cancer at something approaching the rate that cigarettes do. Harvard’s nutrition team calculated that the WHO’s 18% relative risk increase translates, in absolute terms, to a lifetime colorectal cancer risk shifting from roughly 5% to roughly 6%. That is the actual figure. It has never been the headline.
Group 1 means the IARC is confident in the causal relationship and says nothing about magnitude. The relative cancer risk from heavy tobacco use is approximately 1,900%. For daily processed meat consumption it is 18%. Plutonium and solar radiation sit in the same category. So does alcohol. The UICC has noted that presenting relative risks without absolute context predictably misleads the public about dietary risk. The Coalition has built its campaign on exactly that gap.
The vegetable problem nobody is talking about
Then there is the vegetable problem. Nitrates occur naturally in spinach, rocket, celery and beetroot, often at concentrations matching or exceeding those in cured meat. The celery juice used to cure products sold as nitrite-free is itself a concentrated nitrate source. Nobody is campaigning for warning labels on salad bags. The dietary source of nitrates is treated as relevant when it is a rasher of bacon and irrelevant when it is a rocket salad. That inconsistency sits at the centre of the Coalition’s case and has gone unexamined.
The regulator has pushed back. Nobody noticed.
What makes the current situation genuinely striking is not the Coalition’s claims but the regulator’s response to them.
In October, showdown talks between the FSA and the Coalition ended in deadlock. More significantly, the FSA’s own acting chief scientific adviser, Rick Mumford, stated on the record that increased health risks “apply to processed meat overall, not specifically to nitrites” and that there is “no evidence” that removing nitrites makes processed meat safer. That is a direct contradiction of the Coalition’s central proposition: that nitrites specifically are the problem and that reformulated products are meaningfully safer.
The government’s own food safety body said the opposite. That finding has sat almost entirely in trade press. The Guardian’s coverage of the sales slump made no mention of it. Cross-party parliamentarians are pressing supermarkets to delist products on a health premise the regulator has publicly rejected.
The science behind the nitrite scare is contested, the risk data has been routinely misrepresented, and the regulator has said so publicly, but the media and the general public have yet to notice.
The market data tells a more complicated story
The market data tells a more complicated story than last week’s coverage allowed. The £18.7 million fall in nitrite-cured bacon over twelve weeks is significant. But separate Worldpanel by Numerator figures show total bacon sales declined 4.9% in the year to November, falling to £1.03 billion.
Nitrite-free bacon grew 2.9% across the same period, reaching just over £31 million. The segment held up as the healthy alternative accounts for around 3% of total bacon sales by value. Shoppers are not switching to nitrite-free in the volumes the narrative requires.
Many are simply buying less bacon, so this not a reformulation success story and more like a category in contraction, driven by fear that the evidence does not support at the scale being implied.
The direction of travel is clear. The French National Assembly voted 93 to 1 in favour of a timetable to phase out nitrites. Major French producers, including Herta and Fleury Michon, have moved to nitrite-free ranges across large parts of their portfolio.
That shift happened not because the science was settled but because producers who contested nothing ceded the argument, and the market restructured around those who moved first. The UK is following the same pattern, roughly a decade behind. The £18.7 million lost in twelve weeks is a position on a trend.
The arguments that could change this conversation are available. The absolute risk figures are on Harvard’s own website while the FSA’s position is a matter of public record. What is missing is anyone willing to make the case plainly to a general audience. The question for producers and retailers is whether they engage with the evidence now or find themselves explaining the category’s decline later.
